Come up with a name for your new list and we'll add to it:
Chronix Biomedical raised a round of funding on May 18, 2017. Investors include
PrairieGold Venture Partners.
Chronix Biomedical is a US-based molecular diagnostics company developing blood tests primarily for the screening and monitoring of cancer. Chronix offers supplemental screening evaluation tests based…